Close Menu
Home › Personalis

Personalis

Sep 27, 2019

In Brief This Week: Exagen, EKF Diagnostics, Danaher, and More

Sep 25, 2019

IPO Window Wide Open for Dx, Genomics Companies

Premium

Industry experts say a receptive market and investor interest in new technologies have spurred the increase in genomics tools and molecular diagnostics IPOs. 

Jun 28, 2019

In Brief This Week: Invitae, Exact Sciences, Danaher, and More

Get the latest news from Invitae, Exact Sceicnes, Danaher, SkylineDx, Personalis, and Seegene for the week of 6/28/19.

May 24, 2019

In Brief This Week: Invivoscribe, Todos Medical, Personalis, and More

Get the latest news from Ivivoscribe, Todos Medical, Personalis, and Thermo Fisher Scientific for the week of 5/24/19.

Apr 27, 2018

In Brief This Week: Enzo Biochem, Personalis, MDxHealth, IntegraGen, and More

Enzo Biochem and its subsidiary Enzo Life Sciences announced this week that the Patent Trial and Appeal Board has denied a petition filed by Hologic for inter partes review, a procedure for challenging the validity of patent claims, against US Patent 6,221,581.

Nov 17, 2017

In Brief This Week: SQI Diagnostics, ArcherDX, CareDx, and More

Apr 24, 2017

NY Department of Health Approves Personalis' ACE Exome Testing

The firm has received approval for two unspecified clinical tests, with a permit under the molecular genetic testing category.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.